My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

13.73 +3.68 (+36.62%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ventyx Biosciences, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

6 Analysts Have This to Say About Ventyx Biosciences ↗

November 17, 2022

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

This Inflammatory Disease Focused Stock Is Well Positioned For $12B Crohn's Disease Market ↗

August 16, 2022

Via Benzinga

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

Earnings Outlook For Ventyx Biosciences ↗

November 02, 2022

Ventyx Biosciences (NASDAQ:VTYX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Ventyx...

Via Benzinga

Stifel Maintains Buy Rating for Ventyx Biosciences: Here's What You Need To Know ↗

September 16, 2022

Stifel has decided to maintain its Buy rating of Ventyx Biosciences (NASDAQ:VTYX) and raise its price target from $45.00 to $53.00. Shares of Ventyx Biosciences are trading up 4.1% over the last 24...

Via Benzinga

Dow To $45? Here Are 5 Other Price Target Changes For Tuesday ↗

September 13, 2022

Jefferies cut the price target on Dow Inc. (NYSE: DOW) from $71 to $45. Jefferies analyst Laurence Alexander also downgraded the stock from Buy to Hold. Dow shares fell 0.8% to $50.55 in pre-market...

Via Benzinga

NIO, Lucid Group And Other Big Gainers From Monday ↗

September 13, 2022

U.S. stocks closed higher with the Dow Jones surging more than 200 points on Monday. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher ↗

September 12, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Monday.

Via Benzinga

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 12, 2022

Via Benzinga

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

Dow Jumps 250 Points; Crude Oil Rises Over 1% ↗

September 12, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Monday.

Via Benzinga

ASTS Stock: What to Know as AST SpaceMobile’s BlueWalker 3 Reaches Orbit ↗

September 12, 2022

AST SpaceMobile (ASTS) stock is in the news Monday as the company's BlueWalker 3 satellite entered Earth's orbit over the weekend.

Via InvestorPlace

Why Is Ventyx Biosciences (VTYX) Stock Up 70% Today? ↗

September 12, 2022

Ventyx Biosciences (VTYX) stock is rocketing higher on Monday after Oppenheimer analyst Jeff Jones provided an update on the shares.

Via InvestorPlace

US Stocks Open Higher, Nasdaq Surges Over 100 Points ↗

September 12, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 12, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022 ↗

September 01, 2022

Upgrades

Via Benzinga

4 Analysts Have This to Say About Ventyx Biosciences ↗

September 01, 2022

Over the past 3 months, 4 analysts have published their opinion on Ventyx Biosciences (NASDAQ:VTYX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...

Via Benzinga

Nasdaq Falls 75 Points; Ventyx Biosciences Shares Spike Higher ↗

August 16, 2022

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 75 points on Tuesday.

Via Benzinga

This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday ↗

August 17, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 16, 2022

Via Benzinga

Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session ↗

August 16, 2022

Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 15, 2022

Via Benzinga

Ventyx Sees Initiation Of Mid-Stage Psoriasis Study In Q4 2022 Following Positive Data From Initial-Stage Study ↗

August 15, 2022

Ventyx Biosciences (NASDAQ: VTYX) announced positive data from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) trial of VTX958, a novel and selective allosteric TYK2...

Via Benzinga

Alibaba, Zoom Video And 76 Biggest Movers From Yesterday ↗

July 12, 2022

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022 ↗

May 09, 2022

Upgrades

Via Benzinga

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.